51 related articles for article (PubMed ID: 22941498)
1.
Tafreshi M; Guan J; Gorrell RJ; Chew N; Xin Y; Deswaerte V; Rohde M; Daly RJ; Peek RM; Jenkins BJ; Davies EM; Kwok T
Front Cell Infect Microbiol; 2018; 8():22. PubMed ID: 29468142
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthetase genotype and Helicobacter pylori infection affect gastric cancer risk.
Rafiei A; Hosseini V; Janbabai G; Fazli B; Ajami A; Hosseini-Khah Z; Gilbreath J; Merrell DS
World J Gastroenterol; 2012 Sep; 18(35):4917-24. PubMed ID: 23002365
[TBL] [Abstract][Full Text] [Related]
3. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice.
Aliramaei MR; Khorasgani MR; Rahmani MR; Zarkesh Esfahani SH; Emamzadeh R
Microb Pathog; 2019 Dec; 142():103926. PubMed ID: 31838174
[TBL] [Abstract][Full Text] [Related]
4. A systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccine.
Choudhari SP; Pendleton KP; Ramsey JD; Blanchard TG; Picking WD
J Pharm Sci; 2013 Aug; 102(8):2508-19. PubMed ID: 23794457
[TBL] [Abstract][Full Text] [Related]
5. An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins.
Zhang F; Shi T; Zhang Z; Wang S; Liu J; Li Y; Wang X; Liu K; Guo L
Appl Microbiol Biotechnol; 2024 Feb; 108(1):231. PubMed ID: 38396242
[TBL] [Abstract][Full Text] [Related]
6. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis.
Shirani M; Pakzad R; Haddadi MH; Akrami S; Asadi A; Kazemian H; Moradi M; Kaviar VH; Zomorodi AR; Khoshnood S; Shafieian M; Tavasolian R; Heidary M; Saki M
BMC Infect Dis; 2023 Aug; 23(1):543. PubMed ID: 37598157
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism.
Özbey D; Demiryas S; Akkuş S; Kepil N; Dinç HÖ; Gareayaghi N; Demirci M; Kurt EA; Uysal Ö; Sarıbaş S; Tokman HB; Kocazeybek B
Turk J Gastroenterol; 2023 Apr; 34(4):346-355. PubMed ID: 36789984
[TBL] [Abstract][Full Text] [Related]
8. New CagL Amino Acid Polymorphism Patterns of
Caliskan R; Polat Sari S; Ercan B; Peker KD; Omac Sonmez M; Akgul O; Sapmaz B; Soylu A; Adas GT; Oner YA; Yuksel Mayda P
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556940
[No Abstract] [Full Text] [Related]
9. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.
Singh SP; Ahuja V; Ghoshal UC; Makharia G; Dutta U; Zargar SA; Venkataraman J; Dutta AK; Mukhopadhyay AK; Singh A; Thapa BR; Vaiphei K; Sathiyasekaran M; Sahu MK; Rout N; Abraham P; Dalai PC; Rathi P; Sinha SK; Bhatia S; Patra S; Ghoshal U; Poddar U; Mouli VP; Kate V
Indian J Gastroenterol; 2021 Aug; 40(4):420-444. PubMed ID: 34219211
[TBL] [Abstract][Full Text] [Related]
10. CagL polymorphisms between East Asian and Western Helicobacter pylori are associated with different abilities to induce IL-8 secretion.
Choi YH; Lai J; Kim MA; Kim A; Kim J; Su H; Ge L; Cha JH
J Microbiol; 2021 Aug; 59(8):763-770. PubMed ID: 34061339
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases.
Yadegar A; Mohabati Mobarez A; Zali MR
Cancer Med; 2019 Apr; 8(4):1619-1632. PubMed ID: 30873747
[TBL] [Abstract][Full Text] [Related]
12. CagL polymorphisms D58/K59 are predominant in
Román-Román A; Martínez-Santos VI; Castañón-Sánchez CA; Albañil-Muñoz AJ; González-Mendoza P; Soto-Flores DG; Martínez-Carrillo DN; Fernández-Tilapa G
Gut Pathog; 2019; 11():5. PubMed ID: 30805032
[TBL] [Abstract][Full Text] [Related]
13. Systematic site-directed mutagenesis of the Helicobacter pylori CagL protein of the Cag type IV secretion system identifies novel functional domains.
Bönig T; Olbermann P; Bats SH; Fischer W; Josenhans C
Sci Rep; 2016 Dec; 6():38101. PubMed ID: 27922023
[TBL] [Abstract][Full Text] [Related]
14. Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59.
Tafreshi M; Zwickel N; Gorrell RJ; Kwok T
PLoS One; 2015; 10(7):e0133531. PubMed ID: 26196862
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and gastric cancer: Indian enigma.
Misra V; Pandey R; Misra SP; Dwivedi M
World J Gastroenterol; 2014 Feb; 20(6):1503-9. PubMed ID: 24587625
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori cagL amino acid polymorphisms and its association with gastroduodenal diseases.
Shukla SK; Prasad KN; Tripathi A; Jaiswal V; Khatoon J; Ghsohal UC; Krishnani N; Husain N
Gastric Cancer; 2013 Jul; 16(3):435-9. PubMed ID: 22941498
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran.
Cherati MR; Shokri-Shirvani J; Karkhah A; Rajabnia R; Nouri HR
Microb Pathog; 2017 Jun; 107():413-418. PubMed ID: 28433795
[TBL] [Abstract][Full Text] [Related]
18. Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease.
Saxena A; Shukla S; Prasad KN; Ghoshal UC
Indian J Med Res; 2011 May; 133(5):514-20. PubMed ID: 21623037
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
